Heart Failure Clinical Trial

Jarvik 2000 Heart as a Bridge to Cardiac Transplantation – Pivotal Trial

Summary

The purpose of the study is to determine the safety and effectiveness of the Jarvik 2000 Heart as a bridge to heart transplantation in end-stage heart failure patients who are approved heart transplant candidates.

View Full Description

Full Description

The Jarvik 2000 Heart is a silent compact axial flow impeller pump of 1 inch diameter, weighing 90g with a displacement volume of 25ml. The pump is implanted into the apex of the left ventricle by left thoracotomy, or by mid-sternotomy, or by the subcostal approach. A vascular graft offloads to either the descending thoracic aorta, the ascending thoracic aorta, or the abdominal aorta. The impeller rotates at speeds of 8,000 to 12,000 rpm providing blood flow of up to seven L/minute. At higher speeds the pump can produce 10 L/minute. Power is provided through an abdominal drive line.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria: (The following are general inclusion criteria; more specific criteria are outlined in the study protocol).

Transplant listed UNOS status IA or IB patients.
BSA >1.5 m2 and <2.3 m2.
Dependent on one or more intravenous inotropic agents or an intraaortic balloon pump (IABP).

Exclusion Criteria:(The following are general exclusion criteria; more specific criteria are outlined in the study protocol).

Known risk factors or conditions that would contraindicate LVAD implantation or adversely affect patient survival.
Evidence of end organ dysfunction.
Known coagulopathy or contraindication of anticoagulation or antiplatelet agents.
Systemic infection.
Malignancies not in remission.
Current participation in investigational trials with other devices, drugs, or biologic agents.

Study is for people with:

Heart Failure

Phase:

Phase 2

Estimated Enrollment:

150

Study ID:

NCT00591799

Recruitment Status:

Completed

Sponsor:

Jarvik Heart, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Maryland Medical Center
Baltimore Maryland, 21201, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Phase:

Phase 2

Estimated Enrollment:

150

Study ID:

NCT00591799

Recruitment Status:

Completed

Sponsor:


Jarvik Heart, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider